Preparticipation screening for the detection of cardiovascular abnormalities that may cause sudden death in competitive athletes

British Journal of Sports Medicine

Volumn 37, Issue 1, 2003, Pages 4-5

  Pigozzi, F ^a   Spataro, A ^a   Fagnani, F ^a   Maffulli, N ^b  

^a UNIVERSITY OF ROME FORO ITALICO   (Italy)

^b KEELE UNIVERSITY SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ATHLETE; CARDIOVASCULAR MALFORMATION; ELECTROCARDIOGRAM; HEALTH PROGRAM; HUMAN; LABORATORY TEST; PRACTICE GUIDELINE; RISK ASSESSMENT; SCREENING; SHORT SURVEY; SPORTS MEDICINE; SUDDEN DEATH;

CARDIOVASCULAR DISEASES; DEATH, SUDDEN, CARDIAC; ELECTROCARDIOGRAPHY; HUMANS; MASS SCREENING; RISK FACTORS; SPORTS;

EID: 0037310976     PISSN: 03063674     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjsm.37.1.4     Document Type: Short Survey

References (15)

1. Maron BJ, Shirani J, Poliac LC, et al. Sudden death in young competitive athletes. JAMA 1996;276:199-204.
2. Thiene G, Nava A, Corrado D, et al. Right ventricular cardiomyopathy and sudden death in young people. N Engl J Med 1988;318:129-33
3. Fuller CM, McNully CM, Spring DA, et al. Prospective screening of 5615 high school athletes for risk of sudden cardiac death. Med Sci Sports Exerc 1997;29:1131-8.
4. Maron BJ, Thompson PD, Puffer JC, et al. Cardiovascular pre-participation screening of competitive athletes. Circulation 1996;94:850-6.
5. Corrado D, Bosso C, Schiavon M, et al. Sreening for hypertrophic cardiomyopathy in young athletes. N Engl J Med 1998;339:364-9.
6. Maron BJ. The young competitive athlete with cardiovascular abnormalities: causes of sudden death, detection by preparticipation screening, and standards for disqualification. Card Electrophysiol Rev 2002;6:100-3.
7. Decree of the Italian Ministry of Health. February 19, 1982. Norme per la tutela dell'attività agonistica. Gazzetta Ufficiale 1982:Mar 5:63.
8. Pelliccia A, Maron BJ. Preparticipation cardiovascular evalutation of the competitive athlete: perspectives from the 30-year Italian experience. Am J Cardiol 1995;75:827-9.
9. Venerando A, Rulli V. Frequency, morphology and meaning of the electrocardiographic anomalies found in Olympic marathon runners. J Sports Med 1964;3:135-41.
10. Hanne-Paparo N, Wendkos MH, Brunner DT. T wave abnormalities in the electrocardiograms of top-ranking athletes without demonstrable organic heart disease. Am Heart J 1971;81:743-7.
11. Lichtman J, O'Rourke RA, Klein A, et al. Electrocardiogram of the athlete: alterations simulating those of organic heart disease. Arch Intern Med 1973;132:763-70.
12. Pelliccia A, Maron BJ, Culasso F, et al. Clinical significance of abnormal electrocardiographic patterns in trained athletes. Circulation 2000;102:278-84.
13. Pelliccia A, Cullasso F, Di Paolo FM, et al. Physiologic left ventricular cavity dilatation in élite athletes. Ann Intern Med 1999;130:23-31.
14. Pelliccia A, Maron BJ, Spataro A, et al. The upper limit of physiologic cardiac hypertrophy in highly trained élite athletes. N Engl J Med 1991;324:295-301.
15. Pelliccia A, Caselli G, Biffi A, et al. Utility of routinary echocardiography in the screening of a large population of top-athletes. Proceedings II International Conference Sports Cardiology. Bologna: Aulo Gaggi Publishers, 1989:367-72.